Wayne A Ray. Am J Epidemiol 2003
Times Cited: 1137
Times Cited: 1137
Times Cited
Times Co-cited
Similarity
The active comparator, new user study design in pharmacoepidemiology: historical foundations and contemporary application.
Jennifer L Lund, David B Richardson, Til Stürmer. Curr Epidemiol Rep 2015
Jennifer L Lund, David B Richardson, Til Stürmer. Curr Epidemiol Rep 2015
16
Data Resource Profile: Clinical Practice Research Datalink (CPRD).
Emily Herrett, Arlene M Gallagher, Krishnan Bhaskaran, Harriet Forbes, Rohini Mathur, Tjeerd van Staa, Liam Smeeth. Int J Epidemiol 2015
Emily Herrett, Arlene M Gallagher, Krishnan Bhaskaran, Harriet Forbes, Rohini Mathur, Tjeerd van Staa, Liam Smeeth. Int J Epidemiol 2015
15
Prevalent new-user cohort designs for comparative drug effect studies by time-conditional propensity scores.
Samy Suissa, Erica E M Moodie, Sophie Dell'Aniello. Pharmacoepidemiol Drug Saf 2017
Samy Suissa, Erica E M Moodie, Sophie Dell'Aniello. Pharmacoepidemiol Drug Saf 2017
12
Using Big Data to Emulate a Target Trial When a Randomized Trial Is Not Available.
Miguel A Hernán, James M Robins. Am J Epidemiol 2016
Miguel A Hernán, James M Robins. Am J Epidemiol 2016
11
Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples.
Peter C Austin. Stat Med 2009
Peter C Austin. Stat Med 2009
9
Active-comparator design and new-user design in observational studies.
Kazuki Yoshida, Daniel H Solomon, Seoyoung C Kim. Nat Rev Rheumatol 2015
Kazuki Yoshida, Daniel H Solomon, Seoyoung C Kim. Nat Rev Rheumatol 2015
9
Variable selection for propensity score models.
M Alan Brookhart, Sebastian Schneeweiss, Kenneth J Rothman, Robert J Glynn, Jerry Avorn, Til Stürmer. Am J Epidemiol 2006
M Alan Brookhart, Sebastian Schneeweiss, Kenneth J Rothman, Robert J Glynn, Jerry Avorn, Til Stürmer. Am J Epidemiol 2006
8
The incident user design in comparative effectiveness research.
Eric S Johnson, Barbara A Bartman, Becky A Briesacher, Neil S Fleming, Tobias Gerhard, Cynthia J Kornegay, Parivash Nourjah, Brian Sauer, Glen T Schumock, Art Sedrakyan,[...]. Pharmacoepidemiol Drug Saf 2013
Eric S Johnson, Barbara A Bartman, Becky A Briesacher, Neil S Fleming, Tobias Gerhard, Cynthia J Kornegay, Parivash Nourjah, Brian Sauer, Glen T Schumock, Art Sedrakyan,[...]. Pharmacoepidemiol Drug Saf 2013
8
High-dimensional propensity score adjustment in studies of treatment effects using health care claims data.
Sebastian Schneeweiss, Jeremy A Rassen, Robert J Glynn, Jerry Avorn, Helen Mogun, M Alan Brookhart. Epidemiology 2009
Sebastian Schneeweiss, Jeremy A Rassen, Robert J Glynn, Jerry Avorn, Helen Mogun, M Alan Brookhart. Epidemiology 2009
8
An Introduction to Propensity Score Methods for Reducing the Effects of Confounding in Observational Studies.
Peter C Austin. Multivariate Behav Res 2011
Peter C Austin. Multivariate Behav Res 2011
8
Propensity score methods for confounding control in nonexperimental research.
M Alan Brookhart, Richard Wyss, J Bradley Layton, Til Stürmer. Circ Cardiovasc Qual Outcomes 2013
M Alan Brookhart, Richard Wyss, J Bradley Layton, Til Stürmer. Circ Cardiovasc Qual Outcomes 2013
8
Specifying a target trial prevents immortal time bias and other self-inflicted injuries in observational analyses.
Miguel A Hernán, Brian C Sauer, Sonia Hernández-Díaz, Robert Platt, Ian Shrier. J Clin Epidemiol 2016
Miguel A Hernán, Brian C Sauer, Sonia Hernández-Díaz, Robert Platt, Ian Shrier. J Clin Epidemiol 2016
8
Observational studies analyzed like randomized experiments: an application to postmenopausal hormone therapy and coronary heart disease.
Miguel A Hernán, Alvaro Alonso, Roger Logan, Francine Grodstein, Karin B Michels, Walter C Willett, Joann E Manson, James M Robins. Epidemiology 2008
Miguel A Hernán, Alvaro Alonso, Roger Logan, Francine Grodstein, Karin B Michels, Walter C Willett, Joann E Manson, James M Robins. Epidemiology 2008
7
A basic study design for expedited safety signal evaluation based on electronic healthcare data.
Sebastian Schneeweiss. Pharmacoepidemiol Drug Saf 2010
Sebastian Schneeweiss. Pharmacoepidemiol Drug Saf 2010
6
A review of uses of health care utilization databases for epidemiologic research on therapeutics.
Sebastian Schneeweiss, Jerry Avorn. J Clin Epidemiol 2005
Sebastian Schneeweiss, Jerry Avorn. J Clin Epidemiol 2005
6
Validation and validity of diagnoses in the General Practice Research Database: a systematic review.
Emily Herrett, Sara L Thomas, W Marieke Schoonen, Liam Smeeth, Andrew J Hall. Br J Clin Pharmacol 2010
Emily Herrett, Sara L Thomas, W Marieke Schoonen, Liam Smeeth, Andrew J Hall. Br J Clin Pharmacol 2010
6
Problem of immortal time bias in cohort studies: example using statins for preventing progression of diabetes.
Linda E Lévesque, James A Hanley, Abbas Kezouh, Samy Suissa. BMJ 2010
Linda E Lévesque, James A Hanley, Abbas Kezouh, Samy Suissa. BMJ 2010
6
Immortal time bias in observational studies of drug effects.
Samy Suissa. Pharmacoepidemiol Drug Saf 2007
Samy Suissa. Pharmacoepidemiol Drug Saf 2007
6
Negative controls: a tool for detecting confounding and bias in observational studies.
Marc Lipsitch, Eric Tchetgen Tchetgen, Ted Cohen. Epidemiology 2010
Marc Lipsitch, Eric Tchetgen Tchetgen, Ted Cohen. Epidemiology 2010
6
One-to-many propensity score matching in cohort studies.
Jeremy A Rassen, Abhi A Shelat, Jessica Myers, Robert J Glynn, Kenneth J Rothman, Sebastian Schneeweiss. Pharmacoepidemiol Drug Saf 2012
Jeremy A Rassen, Abhi A Shelat, Jessica Myers, Robert J Glynn, Kenneth J Rothman, Sebastian Schneeweiss. Pharmacoepidemiol Drug Saf 2012
5
Transparency and Reproducibility of Observational Cohort Studies Using Large Healthcare Databases.
S V Wang, P Verpillat, J A Rassen, A Patrick, E M Garry, D B Bartels. Clin Pharmacol Ther 2016
S V Wang, P Verpillat, J A Rassen, A Patrick, E M Garry, D B Bartels. Clin Pharmacol Ther 2016
5
Metrics for covariate balance in cohort studies of causal effects.
Jessica M Franklin, Jeremy A Rassen, Diana Ackermann, Dorothee B Bartels, Sebastian Schneeweiss. Stat Med 2014
Jessica M Franklin, Jeremy A Rassen, Diana Ackermann, Dorothee B Bartels, Sebastian Schneeweiss. Stat Med 2014
5
Marginal structural models as a tool for standardization.
Tosiya Sato, Yutaka Matsuyama. Epidemiology 2003
Tosiya Sato, Yutaka Matsuyama. Epidemiology 2003
5
Marginal structural models and causal inference in epidemiology.
J M Robins, M A Hernán, B Brumback. Epidemiology 2000
J M Robins, M A Hernán, B Brumback. Epidemiology 2000
5
A Propensity-score-based Fine Stratification Approach for Confounding Adjustment When Exposure Is Infrequent.
Rishi J Desai, Kenneth J Rothman, Brian T Bateman, Sonia Hernandez-Diaz, Krista F Huybrechts. Epidemiology 2017
Rishi J Desai, Kenneth J Rothman, Brian T Bateman, Sonia Hernandez-Diaz, Krista F Huybrechts. Epidemiology 2017
5
Effects of adjusting for instrumental variables on bias and precision of effect estimates.
Jessica A Myers, Jeremy A Rassen, Joshua J Gagne, Krista F Huybrechts, Sebastian Schneeweiss, Kenneth J Rothman, Marshall M Joffe, Robert J Glynn. Am J Epidemiol 2011
Jessica A Myers, Jeremy A Rassen, Joshua J Gagne, Krista F Huybrechts, Sebastian Schneeweiss, Kenneth J Rothman, Marshall M Joffe, Robert J Glynn. Am J Epidemiol 2011
5
The reporting of studies conducted using observational routinely collected health data statement for pharmacoepidemiology (RECORD-PE).
Sinéad M Langan, Sigrún Aj Schmidt, Kevin Wing, Vera Ehrenstein, Stuart G Nicholls, Kristian B Filion, Olaf Klungel, Irene Petersen, Henrik T Sorensen, William G Dixon,[...]. BMJ 2018
Sinéad M Langan, Sigrún Aj Schmidt, Kevin Wing, Vera Ehrenstein, Stuart G Nicholls, Kristian B Filion, Olaf Klungel, Irene Petersen, Henrik T Sorensen, William G Dixon,[...]. BMJ 2018
5
Metformin and the risk of cancer: time-related biases in observational studies.
Samy Suissa, Laurent Azoulay. Diabetes Care 2012
Samy Suissa, Laurent Azoulay. Diabetes Care 2012
5
Using Real-World Data to Predict Findings of an Ongoing Phase IV Cardiovascular Outcome Trial: Cardiovascular Safety of Linagliptin Versus Glimepiride.
Elisabetta Patorno, Sebastian Schneeweiss, Chandrasekar Gopalakrishnan, David Martin, Jessica M Franklin. Diabetes Care 2019
Elisabetta Patorno, Sebastian Schneeweiss, Chandrasekar Gopalakrishnan, David Martin, Jessica M Franklin. Diabetes Care 2019
11
Marginal structural models to estimate the causal effect of zidovudine on the survival of HIV-positive men.
M A Hernán, B Brumback, J M Robins. Epidemiology 2000
M A Hernán, B Brumback, J M Robins. Epidemiology 2000
5
Calendar time-specific propensity scores and comparative effectiveness research for stage III colon cancer chemotherapy.
Christina DeFilippo Mack, Robert J Glynn, M Alan Brookhart, William R Carpenter, Anne Marie Meyer, Robert S Sandler, Til Stürmer. Pharmacoepidemiol Drug Saf 2013
Christina DeFilippo Mack, Robert J Glynn, M Alan Brookhart, William R Carpenter, Anne Marie Meyer, Robert S Sandler, Til Stürmer. Pharmacoepidemiol Drug Saf 2013
15
Sensitivity analysis and external adjustment for unmeasured confounders in epidemiologic database studies of therapeutics.
Sebastian Schneeweiss. Pharmacoepidemiol Drug Saf 2006
Sebastian Schneeweiss. Pharmacoepidemiol Drug Saf 2006
4
Sensitivity Analysis in Observational Research: Introducing the E-Value.
Tyler J VanderWeele, Peng Ding. Ann Intern Med 2017
Tyler J VanderWeele, Peng Ding. Ann Intern Med 2017
4
Beyond the intention-to-treat in comparative effectiveness research.
Miguel A Hernán, Sonia Hernández-Díaz. Clin Trials 2012
Miguel A Hernán, Sonia Hernández-Díaz. Clin Trials 2012
4
Evidence of the depletion of susceptibles effect in non-experimental pharmacoepidemiologic research.
Y Moride, L Abenhaim. J Clin Epidemiol 1994
Y Moride, L Abenhaim. J Clin Epidemiol 1994
4
Bias in observational studies of prevalent users: lessons for comparative effectiveness research from a meta-analysis of statins.
Goodarz Danaei, Mohammad Tavakkoli, Miguel A Hernán. Am J Epidemiol 2012
Goodarz Danaei, Mohammad Tavakkoli, Miguel A Hernán. Am J Epidemiol 2012
4
Use of stabilized inverse propensity scores as weights to directly estimate relative risk and its confidence intervals.
Stanley Xu, Colleen Ross, Marsha A Raebel, Susan Shetterly, Christopher Blanchette, David Smith. Value Health 2010
Stanley Xu, Colleen Ross, Marsha A Raebel, Susan Shetterly, Christopher Blanchette, David Smith. Value Health 2010
4
Constructing inverse probability weights for marginal structural models.
Stephen R Cole, Miguel A Hernán. Am J Epidemiol 2008
Stephen R Cole, Miguel A Hernán. Am J Epidemiol 2008
4
ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions.
Jonathan Ac Sterne, Miguel A Hernán, Barnaby C Reeves, Jelena Savović, Nancy D Berkman, Meera Viswanathan, David Henry, Douglas G Altman, Mohammed T Ansari, Isabelle Boutron,[...]. BMJ 2016
Jonathan Ac Sterne, Miguel A Hernán, Barnaby C Reeves, Jelena Savović, Nancy D Berkman, Meera Viswanathan, David Henry, Douglas G Altman, Mohammed T Ansari, Isabelle Boutron,[...]. BMJ 2016
4
Real-World Evidence - What Is It and What Can It Tell Us?
Rachel E Sherman, Steven A Anderson, Gerald J Dal Pan, Gerry W Gray, Thomas Gross, Nina L Hunter, Lisa LaVange, Danica Marinac-Dabic, Peter W Marks, Melissa A Robb,[...]. N Engl J Med 2016
Rachel E Sherman, Steven A Anderson, Gerald J Dal Pan, Gerry W Gray, Thomas Gross, Nina L Hunter, Lisa LaVange, Danica Marinac-Dabic, Peter W Marks, Melissa A Robb,[...]. N Engl J Med 2016
4
A combined comorbidity score predicted mortality in elderly patients better than existing scores.
Joshua J Gagne, Robert J Glynn, Jerry Avorn, Raisa Levin, Sebastian Schneeweiss. J Clin Epidemiol 2011
Joshua J Gagne, Robert J Glynn, Jerry Avorn, Raisa Levin, Sebastian Schneeweiss. J Clin Epidemiol 2011
4
Alternative approaches for confounding adjustment in observational studies using weighting based on the propensity score: a primer for practitioners.
Rishi J Desai, Jessica M Franklin. BMJ 2019
Rishi J Desai, Jessica M Franklin. BMJ 2019
4
When and How Can Real World Data Analyses Substitute for Randomized Controlled Trials?
Jessica M Franklin, Sebastian Schneeweiss. Clin Pharmacol Ther 2017
Jessica M Franklin, Sebastian Schneeweiss. Clin Pharmacol Ther 2017
4
Graphical Depiction of Longitudinal Study Designs in Health Care Databases.
Sebastian Schneeweiss, Jeremy A Rassen, Jeffrey S Brown, Kenneth J Rothman, Laura Happe, Peter Arlett, Gerald Dal Pan, Wim Goettsch, William Murk, Shirley V Wang. Ann Intern Med 2019
Sebastian Schneeweiss, Jeremy A Rassen, Jeffrey S Brown, Kenneth J Rothman, Laura Happe, Peter Arlett, Gerald Dal Pan, Wim Goettsch, William Murk, Shirley V Wang. Ann Intern Med 2019
6
Adjusted survival curves with inverse probability weights.
Stephen R Cole, Miguel A Hernán. Comput Methods Programs Biomed 2004
Stephen R Cole, Miguel A Hernán. Comput Methods Programs Biomed 2004
4
Value of a national administrative database to guide public decisions: From the système national d'information interrégimes de l'Assurance Maladie (SNIIRAM) to the système national des données de santé (SNDS) in France.
P Tuppin, J Rudant, P Constantinou, C Gastaldi-Ménager, A Rachas, L de Roquefeuil, G Maura, H Caillol, A Tajahmady, J Coste,[...]. Rev Epidemiol Sante Publique 2017
P Tuppin, J Rudant, P Constantinou, C Gastaldi-Ménager, A Rachas, L de Roquefeuil, G Maura, H Caillol, A Tajahmady, J Coste,[...]. Rev Epidemiol Sante Publique 2017
4
Emulating Randomized Clinical Trials With Nonrandomized Real-World Evidence Studies: First Results From the RCT DUPLICATE Initiative.
Jessica M Franklin, Elisabetta Patorno, Rishi J Desai, Robert J Glynn, David Martin, Kenneth Quinto, Ajinkya Pawar, Lily G Bessette, Hemin Lee, Elizabeth M Garry,[...]. Circulation 2021
Jessica M Franklin, Elisabetta Patorno, Rishi J Desai, Robert J Glynn, David Martin, Kenneth Quinto, Ajinkya Pawar, Lily G Bessette, Hemin Lee, Elizabeth M Garry,[...]. Circulation 2021
7
Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data.
Hude Quan, Vijaya Sundararajan, Patricia Halfon, Andrew Fong, Bernard Burnand, Jean-Christophe Luthi, L Duncan Saunders, Cynthia A Beck, Thomas E Feasby, William A Ghali. Med Care 2005
Hude Quan, Vijaya Sundararajan, Patricia Halfon, Andrew Fong, Bernard Burnand, Jean-Christophe Luthi, L Duncan Saunders, Cynthia A Beck, Thomas E Feasby, William A Ghali. Med Care 2005
4
Number needed to treat is incorrect without proper time-related considerations.
Daniel Suissa, Paul Brassard, Brielan Smiechowski, Samy Suissa. J Clin Epidemiol 2012
Daniel Suissa, Paul Brassard, Brielan Smiechowski, Samy Suissa. J Clin Epidemiol 2012
7
Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.